Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The University of Hertfordshire Higher Education Corporation currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is concentrated under 1 distinct examiner and 1 distinct art unit, indicating a focused prosecution footprint. Such concentration allows for a specialized approach to addressing examiner concerns within this technical field without the need to coordinate across multiple departments.
The busiest examiner for the portfolio is FOX, ALLISON M, who is responsible for the 1 busiest examiner pending office action. Because the count for the busiest examiner matches the total of 1 pending office action, this individual examiner handles the entirety of the corporation's current patent office interactions. Practitioners can focus their strategy on the specific preferences and past actions of FOX, ALLISON M to resolve the outstanding matter.
The alignment of 1 distinct art unit with the Biotechnology & Pharmaceuticals sector suggests that the portfolio's current legal challenges are confined to a specific technical niche. Navigating the 1 distinct examiner requires a deep understanding of that individual's specific requirements and historical allowance rates. This narrow distribution simplifies the administrative tracking of the portfolio's progress through the patent office and reduces the complexity of the legal response.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOX, ALLISON M | 1 | 71.2% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17995736 | METHOD AND APPARATUS FOR THREE DIMENSIONAL ALVEOLAR LUNG MODEL | FOX, ALLISON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17995736 | METHOD AND APPARATUS FOR THREE DIMENSIONAL ALVEOLAR LUNG MODEL | FOX, ALLISON M | — |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17995736 | METHOD AND APPARATUS FOR THREE DIMENSIONAL ALVEOLAR LUNG MODEL | FOX, ALLISON M | 1600 | §102§112 | Non-Final OA | — | Pending | Oct 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial